Literature DB >> 23077078

Telomere length is associated with ACE I/D polymorphism in hypertensive patients with left ventricular hypertrophy.

Frej Fyhrquist1, Anders Eriksson, Outi Saijonmaa, Børge G Nordestgaard, Kimmo Kontula, Ulf de Faire, Hans Ibsen, Sverre Kjeldsen, Ingrid Os, Björn Dahlöf.   

Abstract

INTRODUCTION: Short telomeres are often associated with cardiovascular risk factors and age-related diseases, while the angiotensin converting enzyme (ACE) gene insertion/deletion polymorphism (DD, ID, II) has shown such associations less consistently. We hypothesized that telomere length and association of telomere length with cardiovascular risk is affected by ACE (I/D) genotype.
METHODS: We measured leucocyte telomere length (LTL) by Southern blot and analysed ACE I/D genotypes in 1249 subjects with hypertension and left ventricular hypertrophy (LVH). We examined interactions of ACE I/D genotype with LTL and cardiovascular risk.
RESULTS: Mean LTL in DD or ID genotype was shorter (8.15 and 8.14 kb, respectively), than in II genotype (8.27 kb, p=0.0005). This difference was significant in the younger subjects (55-64 years, p=0.02) but not in the older group (65-80 years, p=0.56 ). In DD but not I/D or II genotype, proportion of short telomeres (<5 kb) was related to Framingham risk score.
CONCLUSIONS: Shorter LTL in genotypes DD or ID suggests a negative effect of the D allele on telomere length. Homozygocity for the D allele appears to strengthen the association of telomere length with increased cardiovascular risk in elderly hypertensive subjects with LVH.

Entities:  

Keywords:  ACE I/D polymorphism; Telomere length; hypertension; left ventricular hypertrophy

Mesh:

Substances:

Year:  2012        PMID: 23077078     DOI: 10.1177/1470320312460292

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  3 in total

Review 1.  Basic Biology of Oxidative Stress and the Cardiovascular System: Part 1 of a 3-Part Series.

Authors:  Michael N Sack; Frej Y Fyhrquist; Outi J Saijonmaa; Valentin Fuster; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2017-07-11       Impact factor: 24.094

Review 2.  The roles of senescence and telomere shortening in cardiovascular disease.

Authors:  Frej Fyhrquist; Outi Saijonmaa; Timo Strandberg
Journal:  Nat Rev Cardiol       Date:  2013-03-12       Impact factor: 32.419

3.  Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis.

Authors:  Adonis Sfera; Carolina Osorio; Carlos M Zapata Martín Del Campo; Shaniah Pereida; Steve Maurer; Jose Campo Maldonado; Zisis Kozlakidis
Journal:  Front Cell Neurosci       Date:  2021-06-25       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.